This "Immune" podcast special features an interview with Dr. Shane Crotty from the La Jolla Institute for Immunology, exploring his journey into science and his influential work in immunology, particularly vaccinology. Dr. Crotty recounts how early exposure to experimental biology through a high school program ignited his scientific interest, leading him to pivot from molecular biology to immunology after observing a critical disconnect between basic immunology and vaccine development. He discusses the significance of T follicular helper (TFH) cells, his favorite cell type, and their crucial role in vaccine-induced antibody responses. A major focus is his lab's rapid and impactful research during the COVID-19 pandemic, where they were among the first to characterize SARS-CoV-2 immune responses, showcasing how agility and collaboration can accelerate scientific breakthroughs. Dr. Crotty concludes by sharing his perspectives on competition and collaboration in science and offers practical advice to trainees, emphasizing learning through rapid experimentation and embracing failure, alongside personal anecdotes about his military background and passion for vaccine development.
Exploring the Scientist Behind the Science: Dr. Shane Crotty on Immunology and Vaccines
0:00 Introduction: Host Cindy Lifer introduces Dr. Shane Crotty from the La Jolla Institute for Immunology, featuring him in a special "office interview" to explore the scientist behind the science.
1:31 Early Scientific Path: Dr. Crotty's initial interest in experimental biology was sparked during high school through an NSF Young Scholars program at the Catalina Island Marine Biology Lab, a rare hands-on experience at the time.
4:48 Undergraduate Research: He chose MIT for college specifically for its unique opportunities for undergraduate students to engage in world-class, hands-on research from their freshman year.
5:52 Transition to Immunology: While in grad school at UCSF, Dr. Crotty's involvement in a partially successful vaccine project revealed a significant disconnect between basic immunology and vaccinology, inspiring him to dedicate his career to bridging this gap and understanding the fundamental principles of effective vaccines.
8:53 The Value of Vaccines: He highlights vaccines as the only medicine recommended for every healthy person, boasting extraordinary economic and health returns, yet notes that most vaccine attempts fail empirically, underscoring the need for a more scientific approach to their design.
10:59 Favorite Cell: TFH Cells: Dr. Crotty identifies T follicular helper (TFH) cells as his favorite, explaining their unique role as a CD4 T cell subset critical for helping B cells form germinal centers, which are essential for long-term B cell memory and robust antibody responses foundational to most successful vaccines.
14:32 Pioneering COVID-19 Research: He recounts his lab's pivotal work in 2020, where, in collaboration with Alex Sette, they were among the first to publish a paper characterizing SARS-CoV-2 specific T-cell and antibody responses in non-hospitalized patients, providing crucial insights for vaccine development.
20:20 Drivers of Rapid Success: Dr. Crotty attributes their lab's unprecedented speed and influence in COVID-19 research to a concentrated hub of human immunology expertise, strong existing collaborations facilitating rapid reagent sharing, and the La Jolla Institute for Immunology's agile "by scientists and for scientists" environment (e.g., swift IRB approvals, core facilities remaining open).
24:28 Unprecedented Research Pace: The lab initiated the COVID-19 project on March 15th, completed all immunological assays for 20 patients by April 15th (within 30 days), and Dr. Crotty, with Alex Sette, analyzed the data and wrote the entire paper in just seven days, leading to publication within 14 days.
26:56 Lasting Impacts on Science: The pandemic experience demonstrated that science can be done much more quickly, fostering positive changes like improved peer review focusing on getting data out and wider acceptance of preprints, though some rapid institutional process (like IRB) changes proved temporary.
30:40 Collaboration and Competition: Dr. Crotty believes in the importance of both collaboration (leveraging diverse expertise for groundbreaking discoveries) and competition (as a necessary, albeit not always pleasant, driver for scientific advancement).
33:05 Advice for Trainees: His primary advice to aspiring scientists is to prioritize experiments that can be done quickly, emphasizing that "failure is a great teacher" and rapid iteration is key to becoming a skilled experimentalist.
35:12 Personal Background: Dr. Crotty reveals a surprising fact: he was a "military kid," having lived in 11 different places before college, a background he suggests likely contributed to his adaptability and openness to diverse perspectives.
37:14 Passion for Vaccines: His core motivation stems from a profound passion for vaccines, recognizing them as among the most valuable medicines globally—saving more children's lives than anything besides clean water—and striving to contribute to their future success.
39:11 Alternative Career: If not a scientist, Dr. Crotty would pursue a career as a writer, having double-majored in biology and writing and already published a book.